Podratz KC - Search Results

1

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer.

Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ Jr, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, Stanhope CR, Wilson TO, Federspiel MJ, Peng KW, Russell SJ. Galanis E, et al. Among authors: podratz kc. Cancer Res. 2010 Feb 1;70(3):875-82. doi: 10.1158/0008-5472.CAN-09-2762. Epub 2010 Jan 26. Cancer Res. 2010. PMID: 20103634 Free PMC article. Clinical Trial.

2

HER-2/neu expression: a major prognostic factor in endometrial cancer.

Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS, Podratz KC. Hetzel DJ, et al. Among authors: podratz kc. Gynecol Oncol. 1992 Nov;47(2):179-85. doi: 10.1016/0090-8258(92)90103-p. Gynecol Oncol. 1992. PMID: 1361478

3

Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.

Hartmann LC, Sebo TJ, Kamel NA, Podratz KC, Cha SS, Wieand HS, Keeney GL, Roche PC. Hartmann LC, et al. Among authors: podratz kc. Gynecol Oncol. 1992 Nov;47(2):191-5. doi: 10.1016/0090-8258(92)90105-r. Gynecol Oncol. 1992. PMID: 1361479

4

Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.

Zanetta GM, Katzmann JA, Keeney GL, Kinney WK, Cha SS, Podratz KC. Zanetta GM, et al. Among authors: podratz kc. Gynecol Oncol. 1992 Jul;46(1):13-9. doi: 10.1016/0090-8258(92)90188-o. Gynecol Oncol. 1992. PMID: 1634134

5

Pelvic exenteration for recurrent cervical cancer.

Stanhope CR, Webb MJ, Podratz KC. Stanhope CR, et al. Among authors: podratz kc. Clin Obstet Gynecol. 1990 Dec;33(4):897-909. doi: 10.1097/00003081-199012000-00026. Clin Obstet Gynecol. 1990. PMID: 2289357 Review. No abstract available.

6

Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma.

Wilson TO, Podratz KC, Gaffey TA, Malkasian GD Jr, O'Brien PC, Naessens JM. Wilson TO, et al. Among authors: podratz kc. Am J Obstet Gynecol. 1990 Feb;162(2):418-23; discussion 423-6. doi: 10.1016/0002-9378(90)90399-r. Am J Obstet Gynecol. 1990. PMID: 2309824

7

DNA ploidy in endometrial carcinoma: major objective prognostic factor.

Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC. Britton LC, et al. Among authors: podratz kc. Mayo Clin Proc. 1990 May;65(5):643-50. doi: 10.1016/s0025-6196(12)65126-x. Mayo Clin Proc. 1990. PMID: 2348728

8

CA 125 in gynecologic practice.

Malkasian GD Jr, Podratz KC, Stanhope CR, Ritts RE Jr, Zurawski VR Jr. Malkasian GD Jr, et al. Among authors: podratz kc. Am J Obstet Gynecol. 1986 Sep;155(3):515-8. doi: 10.1016/0002-9378(86)90269-3. Am J Obstet Gynecol. 1986. PMID: 2428248

9

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.

Malkasian GD Jr, Knapp RC, Lavin PT, Zurawski VR Jr, Podratz KC, Stanhope CR, Mortel R, Berek JS, Bast RC Jr, Ritts RE. Malkasian GD Jr, et al. Among authors: podratz kc. Am J Obstet Gynecol. 1988 Aug;159(2):341-6. doi: 10.1016/s0002-9378(88)80081-4. Am J Obstet Gynecol. 1988. PMID: 2457318

10

Flow cytometric DNA analysis of stage I endometrial carcinoma.

Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieand HS, Podratz KC. Britton LC, et al. Among authors: podratz kc. Gynecol Oncol. 1989 Sep;34(3):317-22. doi: 10.1016/0090-8258(89)90165-0. Gynecol Oncol. 1989. PMID: 2767522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters